|
|
|
Vol. 15, No. 23, pp. 3208-3216, December 1, 2001
TBP/TFIIB and SWI/SNF recruiting domains is required for adipocyte differentiation
1 Laboratory of Gene Therapy Research, Copenhagen University Hospital, 2100 Copenhagen, Denmark; 2 Max-Delbrück-Center for Molecular Medicine, 13125 Berlin, Germany
| |
ABSTRACT |
|---|
|
|
|---|
Chromatin remodeling is an important step in promoter activation
during cellular lineage commitment and differentiation. We show that
the ability of the C/EBP
transcription factor to direct adipocyte
differentiation of uncommitted fibroblast precursors and to activate
SWI/SNF-dependent myeloid-specific genes depends on a domain, C/EBP
transactivation element III (TE-III), that binds the SWI/SNF chromatin
remodeling complex. TE-III collaborates with C/EBP
TBP/TFIIB
interaction motifs during induction of adipogenesis and
adipocyte-specific gene expression. These results indicate that
C/EBP
acts as a lineage-instructive transcription factor through
SWI/SNF-dependent modification of the chromatin structure of
lineage-specific genes, followed by direct promoter activation via
recruitment of the basal transcription-initiation complex, and provide
a mechanism by which C/EBP
can mediate differentiation along
multiple cellular lineages.
[Key Words: Adipocyte; C/EBP; chromatin; differentiation; SWI/SNF; transcription]
| |
Introduction |
|---|
|
|
|---|
The activation of cellular genes is a multistep
process requiring modulation of promoter and enhancer chromatin
structure as a prerequisite for the subsequent binding of specific and
basal transcription factors that direct gene transcription.
Modification of chromatin involves direct modification of the histones
by kinases, methylases, and acetylases, as well as reorganization of
nuclesome structure by chromatin remodeling machines (for review, see
Muller and Leutz 2001
). The role of chromatin remodeling in
lineage-specific gene expression has been investigated in the globin
locus, where it has been found that the erythroid Kruppel-like factor
(EKLF) transcription factor recruits the SWI/SNF complex to the
-globin promoter, resulting in displacement of nucleosomes from and
hypersensitivity of the core promoter region (Armstrong et al. 1998
;
Lee et al. 1999
). EKLF binding to the proximal
-globin promoter
region is required for
-globin transcription in vivo, and
EKLF-deficient mice die from severe
-thalassemia (Perkins et al.
1995
). Recently, it was reported that dominant-negative variants of the
SWI/SNF catalytic core subunits, human Brahma (hBrm) and Brahma-related gene 1 (Brg1), which lack the ATPase activity necessary for chromatin remodeling, inhibit MyoD-dependent induction of muscle-specific gene
transcription in fibroblasts (de La Serna et al. 2001
). These observations
indicate that SWI/SNF-mediated chromatin remodeling is an integral part of
developmental decisions mediated by transcriptional activators.
C/EBP
, the founding member of the C/EBP family, was originally
isolated as an activator of liver-specific transcription. Subsequently,
C/EBP proteins have been shown to regulate the differentiation of
several cell types. C/EBP
is required in vivo for the
differentiation of adipocytes, neutrophil granulocytes, and eosinophils
(Wang et al. 1995
; Zhang et al. 1997
). Moreover, C/EBP
is capable of inducing uncommitted progenitors to differentiate along the
granulocyte, eosinophil, and adipose lineages (Freytag et al. 1994
;
Nerlov et al. 1998
; Radomska et al. 1998
), classifying it as a lineage instructive transcription factor. The induction of eosinophil lineage
commitment by C/EBPs appears to be caused by their ability to
down-regulate the expression of the Friend of GATA (FOG) protein, allowing cooperative activation by C/EBP proteins and GATA-1 (Querfurth et al. 2000
). The activation of chromatin-embedded myeloid genes in
heterologous cell types, such as fibroblasts, has been accomplished by
a combination of Myb and C/EBP transcription factors (Burk et al. 1993
;
Ness et al. 1993
), and this has been shown to involve the recruitment
of the SWI/SNF chromatin-remodeling complex by the N-terminal CR1
region of C/EBP
(Kowenz-Leutz and Leutz 1999
). In the case of the
adipose lineage, the molecular mechanisms are less clear. The inductive
role of C/EBP
in adipogenesis has been correlated to its ability to
up-regulate the expression of PPAR
(Wu et al. 1999
), an essential in
vivo regulator of adipogenesis (Barak et al. 1999
; Lowell 1999
; Rosen
et al. 1999
), as well as the ability of C/EBP
to directly activate
adipocyte-specific promoters (Christy et al. 1989
; Cheneval et al. 1991
).
To address the molecular mechanisms underlying adipocyte
differentiation, we have determined the structural requirements for C/EBP
-mediated conversion of uncommitted fibroblast precursors to
adipocytes. We find that the C/EBP
transactivation element III
(TE-III; Nerlov and Ziff 1994
) is required for adipose conversion, as
well as activation of chromatin-embedded myeloid- and
adipocyte-specific genes, including PPAR
. This region of C/EBP
interacts with the SWI/SNF chromatin remodeling complex, and
collaborates with TBP/TFIIB-interacting motifs in C/EBP
during
adipogenesis, indicating that integration of chromatin remodeling and
recruitment of basal transcription factors forms the basis for the
lineage instructive capacity of C/EBP
.
| |
Results |
|---|
|
|
|---|
The C/EBP
TE-III is required for adipose conversion of
NIH3T3 fibroblasts
C/EBP
is able to mediate the transition of uncommitted
mesenchymal precursor cells to mature adipocytes (Freytag et al. 1994
). In the case of NIH3T3 fibroblasts, induced adipogenesis occurs without
up-regulation of the endogenous C/EBP
gene (Wu et al. 1995
; Yeh et
al. 1995
), making this system well-suited for structure-function analysis of C/EBP
. We infected subconfluent NIH3T3 cultures with pBabePuro-based virus expressing wild-type C/EBP
, as well as C/EBP
lacking each of the three identified C/EBP
transactivation elements (TE-I through III; Nerlov and Ziff 1994
) or amino acids 200-256, containing the putative GSK3 (T222,T226,S230; Ross et al.
1999
) and PKC (S248) phosphorylation sites in C/EBP
(Fig. 1A). These experiments showed that TE-I and
TE-III were required for the induction of expression of the lipoprotein
lipase (LPL), PPAR
, and aP2 mRNAs (Fig. 1B), all coding for proteins
characteristically expressed in adipocytes. Deletion of TE-II or the
GSK3 and PKC phosphorylation sites (aa 200-256) did not significantly
affect C/EBP
-mediated induction of adipocyte gene expression (Fig.
1B), which occurred with kinetics comparable to cells transduced with wild-type C/EBP
(data not shown). For all mutants, gene expression correlated with morphological adipocyte differentiation and
triglyceride accumulation induced by the C/EBP
alleles (Porse et al.
2001
). Stability of the various mutant C/EBP
proteins did not appear to play a role in their differential ability to induce adipocyte differentiation, as judged by their similar expression levels determined by Western blotting (Fig. 1C).
|
The C/EBP
TE-III is required for interaction with the SWI/SNF
chromatin remodeling complex
The functions embedded in the essential TE-I and TE-III regions were
further examined. We have found TE-I to be necessary for the ability of
C/EBP
to repress E2F mediated transcription, and that this is
required for adipocyte differentiation (Porse et al. 2001
). The
function of TE-III was suggested by the observation that this region
has little homology in other C/EBPs, including C/EBP
. The distinct
properties of C/EBP
and C/EBP
were addressed recently by in vivo
gene replacement by Chen et al. (2000)
, who substituted the mouse
C/EBP
coding sequence with that of C/EBP
(generating mice with
the C/EBP
/
genotype), and observed that
differentiation of white adipose tissue was severely impaired. The
C/EBP
coding sequence used to replace C/EBP
lacked the murine
equivalent of the C/EBP
CR1 SWI/SNF interaction domain (Kowenz-Leutz
and Leutz 1999
). This suggested that the lack of proper adipocyte
differentiation in the C/EBP
/
mice was caused by a
defect in SWI/SNF recruitment. We therefore tested the ability of
C/EBP
to interact with SWI/SNF components, and whether TE-III was
necessary and sufficient for this interaction. For this purpose,
full-length C/EBP
(p42), C/EBP
p30 (a C/EBP
form initiated
from the in-frame methionine at position 118), and a deletion mutant
lacking the entire transactivation domain, including TE-III, (D1-215;
Fig. 2A) were C-terminally FLAG-tagged and
cotransfected with HA-tagged hBrm into the Brahma-negative C33A cell
line. The ability of these C/EBP
derivatives to interact with hBrm
was then analyzed by immunoprecipitation with the M2 anti-FLAG
monoclonal antibody, followed by Western blot analysis of the
immunoprecipitate with the PBR-205C monoclonal anti-HA antibody (Fig.
2B). In this assay the C/EBP
p42 and p30 proteins, but not C/EBP
D1-215, were found to associate with hBrm, consistent with TE-III being
a C/EBP
SWI/SNF interaction domain. Indeed, deletion of TE-III was
sufficient to eliminate the C/EBP
-hBrm coprecipitation (Fig. 2C).
Furthermore, after deletion of TE-III, hBrm coprecipitation could be
restored by fusing the heterologous CR1 SWI/SNF recruiting domain from
C/EBP
to the C/EBP
N terminus (Fig. 2A and C, lane 7). The BAF155
core SWI/SNF subunit also coprecipitated with C/EBP
(Fig. 2C). These
results show that TE-III is both necessary and sufficient for C/EBP
to interact with the core SWI/SNF complex in a cellular setting, and
that the structurally unrelated CR1 domain from C/EBP
can
functionally replace TE-III in this respect. Furthermore, these results
show that the N-terminal part (amino acids 1-117) of the C/EBP
transactivation domain unique to C/EBP
p42 is not required for
SWI/SNF interaction by C/EBP
.
|
The ability of C/EBP
TE-III to function as a SWI/SNF-recruiting
domain on chromosomal loci was tested by analyzing the
C/EBP
-mediated induction of the mim-1 and #126 myeloid-specific
transcripts (Ness et al. 1993
). Both of these genomic loci are
activated by C/EBP
in a SWI/SNF-dependent manner in nonmyeloid cell
types, and in the case of mim-1 in collaboration with Myb (Kowenz-Leutz
and Leutz 1999
). QT6 cells were transfected with wild-type C/EBP
and
selected derivatives, both in the presence and the absence of c-Myb
expression, and the expression of mim-1 and #126 was analyzed by
Northern blotting (Fig. 3A). C/EBP
efficiently activated both #126 and mim-1 transcription, the latter in
collaboration with c-Myb. This activation was strongly diminished by
deletion of TE-III. However, TE-III deletion could be functionally
compensated by N-terminal addition of the C/EBP
CR1 domain. Similar
results were obtained in HD3 erythroblasts; here Myb is already
present, and strong TE-III-dependent activation of mim-1 transcription was observed (Fig. 3B). Again TE-III could be functionally replaced by
CR1. The activation of the #325 locus, which is activated by C/EBP
in a SWI/SNF independent manner (Kowenz-Leutz and Leutz 1999
), is shown
as a control for the presence of C/EBP
transactivation in all cases.
Together these data show that C/EBP
TE-III mediates activation of
SWI/SNF-dependent chromosomal loci, indicating that it indeed has
SWI/SNF recruiting activity, and that this is a required function
during C/EBP
-mediated activation of myeloid-specific transcription.
|
SWI/SNF recruitment is essential for C/EBP
-mediated adipogenesis
To assess whether SWI/SNF recruitment was the essential function of
TE-III during adipocyte differentiation, we transduced NIH3T3 cells
with retrovirus encoding C/EBP
, the TE-III deletion mutant, or the
CR1 add-back protein. As can be seen from Figure 4A, this analysis showed that although
deletion of TE-III strongly reduced morphological adipocyte
differentiation, the CR1 domain could efficiently rescue the ability of
C/EBP
to induce morphological adipocyte differentiation (Fig. 4A).
Analysis of adipocyte-specific gene expression showed that the ability
of C/EBP
to activate endogenous adipocyte-specific genes (with
kinetics comparable to wild-type C/EBP
; data not shown), including
that of PPAR
, was abolished by progressive deletion of TE-III, and
restored by the CR1 add-back (Fig. 4B). The level of rescue was
estimated by quantification of triglyceride accumulation and aP2 mRNA
(Fig. 4C), and found to be 50% and 70%, respectively. The <100%
rescue efficiency may be caused by the presence of both SWI/SNF
recruiting and direct transactivation functions within TE-III, only the
former being supplied by CR1 (see Discussion).
|
To further investigate the correlation between SWI/SNF recruitment and
activation of adipocyte gene expression by C/EBP
, we introduced
point mutations into residues of CR1 conserved in vertebrate C/EBP
molecules (Fig. 5A). CR1 was chosen for
this analysis rather than TE-III, because the latter, in addition to its SWI/SNF recruiting activity, harbors activating functions and
negative regulatory elements (Friedman and McKnight 1990
; Nerlov and
Ziff 1994
) that could potentially confound the analysis. These CR1
mutations were introduced into the C/EBP
D126-200+CR1 background
and analyzed for their effect on SWI/SNF interaction in
coimmunoprecipitation assays (as in Fig. 2). The mutations were found
to inhibit (mutLL, mutFR) or abolish (mutWD) the interaction of the
C/EBP
D126-200+CR1 molecule and the SWI/SNF complex, as determined
by coimmunoprecipitation of HA-hBrm (Fig. 5B, panel a), even though
the mutant proteins were expressed and immunoprecipitated at the same
level as the wild-type CR1 fusion (Fig. 5B, panels b and d). The
deficiencies of these mutant molecules in direct SWI/SNF interaction
were paralleled by their decreased ability to activate the
SWI/SNF-dependent mim-1 locus after cotransfection into HD3
erythroblasts (Fig. 5C), as well as aP2 gene expression (Fig. 5D) and
morphological differentiation (data not shown) in NIH3T3 cells on
retroviral transduction. A strong correlation therefore exists between
SWI/SNF recruitment, the ability to activate of SWI/SNF-dependent loci,
and the adipogenic potential of CR1.
|
SWI/SNF and TBP/TFIIB binding motifs of C/EBP
cooperate during
adipocyte differentiation
The C/EBP
transactivation domain contains amino acid motifs,
conserved between the activating C/EBP isoforms, which interact with
the basal transcriptional machinery, both in vitro and in a cellular
context (Nerlov and Ziff 1995
). These motifs reside in the N-terminal
part of the C/EBP
transactivation domain, which is not required
for SWI/SNF interaction. Therefore, we introduced into NIH3T3 cells
a version of C/EBP
in which residues critical for its interaction
with the basal transcription factors TBP and TFIIB have been mutated
(C/EBP
Y67A, FL77, 78AA, or YFL, mutant; Nerlov and Ziff 1995
), and
analyzed the effect on adipogenesis and adipocyte-specific gene
expression. NIH3T3 cells transduced with C/EBP
YFL differentiated
poorly, both by morphological criteria (Fig.
6A) and as measured by their expression of
LPL, PPAR
, and aP2 mRNAs (Fig. 6B). Quantification of Oil Red O
staining and aP2 mRNA expression indicated a 80%-90% loss of
adipogenic potential in the YFL mutant (Fig. 6C), despite expression of
the mutant protein to a similar extent as wild-type C/EBP
(Fig. 6D).
These results show that the C/EBP
TBP/TFIIB interaction motifs are required for C/EBP
-mediated activation of the chromosomal loci encoding the adipocyte-specific markers LPL, PPAR
, and aP2.
|
| |
Discussion |
|---|
|
|
|---|
SWI/SNF action in differentiation and lineage-specific gene expression
The results presented here show that C/EBP
interacts with the
SWI/SNF complex via its TE-III, and that TE-III is required for
C/EBP
-mediated activation of SWI/SNF-dependent myeloid genes, as
well as for C/EBP
-mediated adipogenesis. The structurally unrelated
C/EBP
CR1 SWI/SNF recruiting domain could replace TE-III, and
mutation of residues within CR1 that compromised its SWI/SNF recruiting
capacity reduced or abolished its ability to compensate for deletion of
TE-III. Together, these results strongly support that SWI/SNF
recruitment is the critical function of TE-III, which is complemented
by CR1. In addition to the SWI/SNF recruiting function identified here,
TE-III has been shown previously to participate in direct promoter
activation (Friedman and McKnight 1990
; Nerlov and Ziff 1994
), which is
not the case for CR1 (Kowenz-Leutz and Leutz 1999
). This is likely to
account for <100% rescue of adipocyte gene expression that we
observe. Previous reports have shown that SWI/SNF is involved in the
transcription of the erythroid lineage-specific
-globin locus and in
activation of chromosomal myeloid-specific loci (Armstrong et al. 1998
;
Kowenz-Leutz and Leutz 1999
; Lee et al. 1999
). More recently, de la
Serna et al. (2001)
have shown that dominant-negative hBrm and Brg1
molecules block the induction of myogenesis and muscle-specific gene
expression by MyoD in NIH3T3 cells. The present results show that
SWI/SNF recruitment by a lineage-specific transcription factor directly mediates lineage commitment and differentiation in a mammalian species,
and in addition provide a molecular mechanism by which C/EBP
can
mediate the differentiation of distinct cell types.
Generating specificity of C/EBP
function
The C/EBP
transcription factor has the capability to execute
various differentiation programs. In hematopoiesis, both eosinophil and
neutrophil lineage commitment can be induced by C/EBP
(Nerlov et al.
1998
; Radomska et al. 1998
), and adipogenesis can be initiated by
C/EBP
in uncommitted mesenchymal precursor cells (Freytag et al.
1994
) or, in collaboration with PPAR
, in myocytes (Hu et al. 1995
).
These observations suggest that C/EBP
provides a fundamental
function generally required for the activation of specific
differentiation programs, and that the collaborating factors (PPAR
,
GATA-1, Myb, PU.1) serve to direct this function to appropriate gene
loci. The requirement for the SWI/SNF interacting TE-III domain of
C/EBP
in both adipose conversion of NIH3T3 cells and in activation
of SWI/SNF-dependent myeloid-specific gene expression (in the case of
mim-1, in collaboration with c-Myb) provides evidence that the capacity
to recruit SWI/SNF chromatin remodeling complexes is such a function.
This is further supported by the previous demonstration that providing
a "selector" molecule such as c-Myb (which by itself does not
recruit SWI/SNF) with an SWI/SNF recruiting domain rendered it
functionally independent of C/EBP activity for myeloid-specific gene
activation (Kowenz-Leutz and Leutz 1999
). Together, these observations
lead us to propose that SWI/SNF recruitment is an integral part of
C/EBP
-dependent (and C/EBP
-dependent) differentiation processes.
As mentioned above, the inability of a C/EBP
molecule lacking the
CR1 SWI/SNF binding domain to replace C/EBP
in adipogenesis, without
affecting liver gene expression (Chen et al. 2000
), provides in vivo
evidence that SWI/SNF recruitment is indeed relevant for adipogenesis.
Collaboration between chromatin remodeling and direct promoter activation
Whereas the p42-specific part of the C/EBP
transactivation domain
is dispensable for the interaction between C/EBP
and the SWI/SNF
complex, it still harbors functions required for adipocyte (this paper)
and eosinophil differentiation (Nerlov et al. 1998
). Mutation of two
TBP and TFIIB interaction motifs (Nerlov and Ziff 1995
) that reside in
this part of C/EBP
almost completely blocks induction of
adipocyte-specific genes, demonstrating that abolishing the capacity of
C/EBP
to interact with the basal transcription apparatus blocks
C/EBP
-mediated adipogenesis. In vitro analysis of
-globin
promoter activation by EKLF has shown that SWI/SNF mediated
promoter chromatin remodeling was necessary, but not sufficient, for
promoter activity (Armstrong et al. 1998
), and Imbalzano et al. (1994)
have shown that SWI/SNF-mediated chromatin remodeling facilitates
binding of TBP to a nucleosomal template. All these results are
consistent with a model in which C/EBP
induces SWI/SNF-mediated
chomatin remodeling, facilitating subsequent recruitment of the
basal transcriptional machinery, and indicate that such mechanisms
operate generally during cellular lineage commitment and differentiation.
| |
Materials and methods |
|---|
|
|
|---|
DNA constructs
Rat C/EBP
deletion mutants (Nerlov and Ziff 1994
) and
transactivation domain point mutant (C/EBP
Y,FL; Nerlov and Ziff
1995
) have been described previously. All C/EBP
derivatives were
cloned into pBabePuro (Morgenstern and Land 1990
) for
retroviral infection as BamHI-EcoRI fragments.
C/EBP
D126-200+CR1 and mutant derivatives were amplified by PCR from
pBabePuro r
D126-200 using a 5' primer encoding the first 21 amino
acids of full-length mouse C/EBP
(CR1; Kowenz-Leutz et al. 1994
) or
primers encoding mutant versions of CR1. The PCR fragment was cloned
into pBabePuro using BamHI and EcoRI. All C/EBP
derivatives produced by PCR were confirmed by DNA sequencing. The
pCRNCM and pCRNCM-Myb expression vector has been described previously
(Lim et al. 1992
). C-terminal FLAG tagging of C/EBP
was performed
using an oligonucleotide adapter, and FLAG fusion proteins were
expressed from pcDNA3 (Invitrogen).
Retroviral infection and adipocyte differentiation
NIH3T3 cells (provided by Dr. Karsten Kristiansen, University of
Southern Denmark, Denmark) and Phoenix-E ecotropic retroviral packaging
cells (from Dr. G. Nolan, Stanford University, San Francisco, California) were grown in Dulbecco's modified Eagles medium (DMEM) containing 10% FBS. Retroviral stocks were obtained by transiently transfecting Phoenix-E cells with pBabePuro-based proviral constructs using calcium phosphate coprecipitation. Forty-eight hours after transfection culture supernatants were harvested and filtered through
0.45 µm sterile filters (Millipore). The resulting viral stocks were
used to infect subconfluent layers (30%-50% confluence) of NIH3T3
cells overnight in the presence of 100 µg/mL polybrene (Sigma). After
infection, cells were cultured in DMEM plus 10% FBS (without any
addition of adipogenic effectors) for 2 wk in puromycin-containing
medium (1 µg/mL, Sigma) to allow differentiation to occur. Parallel
cultures were used for preparation of total cellular protein or RNA
preparation, or fixed and stained with Oil Red O (Ramirez-Zacarias et
al. 1992
).
Endogenous gene activation assay
HD3 erythroblasts and quail QT6 fibroblasts (Beug et al. 1979
) were
grown in DMEM supplemented with 8% fetal calf serum, 2% heat-inactivated chicken serum, and antibiotics. To monitor endogenous gene activation in HD3 or QT6 cells, 2 × 107 or
8 × 106 cells, respectively, were transfected with
C/EBP
and Myb expression vectors using DEAE-dextran (Kowenz-Leutz et
al. 1994
), and RNA harvested 16-24 h posttransfection.
RNA isolation and Northern blotting
Total cellular RNA was prepared according to Chromzynski and Sacchi
(1987)
. Poly(A) RNA was isolated using magnetic oligo(dT) beads
according to the manufacturer's instructions (Dynal). RNA (25 µg of
total RNA from NIH3T3 cells; poly(A) RNA from 2 × 107 HD3
cells or 8 × 106 QT6 cells) was run on a 1.2% agarose gel
(in 20 mM MOPS at pH 7.0, 50 mM Na-acetate, 1 mM EDTA, and 1.5%
formaldehyde) for 500 Vh. RNA was capillary blotted overnight onto
BiodyneB membranes (Life Technologies) or Hybond N+ membranes
(Amersham). Blots were prehybridized (30 min at 65°C) and hybridized
(overnight at 65°C) in Quick-Hyb hybridization solution (Stratagene).
Stringent washes were at 65°C in 0.2× SSC 0.1% SDS (60°C for QT6
and HD3 blots). The Northern blots were analyzed using a Fuji BAS2500
phosphorimager and ImageGauge software, or exposed to Kodak XAR X-ray
film. cDNA probes were human LPL cDNA (Wion et al. 1987
), mouse
PPAR
, and aP2 cDNAs (obtained from Dr. Karsten Kristiansen,
University of Southern Denmark, Denmark), mouse GAPDH (Hanauer and
Mandel 1984
) and chicken mim-1, #126, and GAPDH (Nakano and Graf 1992
).
Probes were labeled with [
-32P]dCTP (Amersham-Pharmacia)
using random priming (RadPrime; GIBCO BRL) according to the
instructions supplied by the manufacturer.
Western blotting
Virally infected NIH3T3 cells were lysed in SDS sample buffer,
incubated at 95°C for 5 min, centrifuged to remove insoluble components, and the lysates separated on 12.5% SDS-PAGE gels (200 Vh).
Proteins were transferred to PVDF membranes (Millipore) using semi-dry
transfer. Membranes were blocked in TBS-T (100 mM Tris at pH 7.5, 150 mM NaCl, 0.1% Tween 20) containing 10% nonfat dry milk overnight at
4°C, incubated with primary antibody (C103 rabbit anti-C/EBP
antiserum; Nerlov and Ziff 1994
), PRB-205C anti-HA antibody (BAbCO,
Freiburg, Germany), M2 anti-FLAG antibody (Sigma) or anti-BAF155
antiserum (Kowenz-Leutz and Leutz 1999
) in TBS-T for 1 h at room
temperature, followed by appropriate horseradish peroxidase-conjugated
secondary antibody (Amersham-Pharmacia; 1:5000 in TBS-T; 1 h at
room temperature) with three 5' washes in TBS-T after each incubation.
Blots were developed using enhanced chemiluminescence (ECL;
Amersham-Pharmacia).
Coimmunoprecipitation
A total of 5 × 106 C33A cells were transfected with 5 µg of the expression vectors indicated, using calcium phosphate
coprecipitation. Cell lysates were prepared and immunoprecipitated as
described previously (Kowenz-Leutz and Leutz 1999
) using anti-FLAG M2
antibodies (Kodak). Immunoprecipitates were boiled in SDS sample buffer
and subjected to Western blotting.
| |
Acknowledgments |
|---|
We thank Drs. Kristian Helin, Karsten Kristiansen and Gary Nolan for kind gifts of plasmids and cell lines. This work was supported by the Danish Medical Research Council, the Danish Cancer Society, the Novo Nordisk Foundation (C.N.), and the Deutsche Forschungsgemeinschaft (DFG LE770/1-2) (A.L.).
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| |
Footnotes |
|---|
Received June 11, 2001; revised version accepted September 28, 2001.
3 These authors contributed equally to this work.
4 Corresponding authors.
E-MAIL aleutz{at}mdc-berlin.de; FAX 49-30-9406-3298.
E-MAIL nerlov{at}embl-monterotundo.it; FAX 39-06-9009-1272.
Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.209901.
| |
References |
|---|
|
|
|---|
is required for placental, cardiac, and adipose tissue development.
Mol. Cell
4:
585-595[CrossRef][Medline].
, when expressed from the C/ebp
gene locus, can functionally replace C/EBP
in liver but not in adipose tissue.
Mol. Cell. Biol.
20:
7292-7299
promotes the adipogenic program in a variety of mouse fibroblastic cells.
Genes & Dev.
8:
1654-1663
and C/EBP
.
Proc. Natl. Acad. Sci.
92:
9856-9860
isoform recruits the SWI/SNF complex to activate myeloid genes.
Mol. Cell
4:
735-743[CrossRef][Medline].
(NF-M) transcriptional control: Activation through derepression.
Genes & Dev.
8:
2781-2791
-globin promoter in erythroid cells.
Proc. Natl. Acad. Sci.
96:
12311-12315
: An essential regulator of adipogenesis and modulator of fat cell function.
Cell
99:
239-242[CrossRef][Medline].
on the serum albumin promoter.
Genes & Dev.
8:
350-362
amino acid motifs with dual TBP and TFIIB binding ability co-operate to activate transcription in both yeast and mammalian cells.
EMBO J.
14:
4318-4328[Medline].
-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF.
Nature
375:
318-322[CrossRef][Medline].
is required for adipogenesis and granulopoiesis in vivo.
Cell
107:
247-258[CrossRef][Medline].
and FOG in eosinophil lineage commitment of multipotent hematopoietic progenitors.
Genes & Dev.
14:
2515-2525
is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors.
Mol. Cell. Biol.
18:
4301-4314
is required for the differentiation of adipose tissue in vivo and in vitro.
Mol. Cell
4:
611-617[CrossRef][Medline].
kinase.
Mol. Cell. Biol.
19:
8433-8441
knockout mice.
Science
269:
1108-1112
in NIH-3T3 cells induces PPAR
and stimulates adipogenesis.
Genes & Dev.
9:
2350-2363
and PPAR
controls the transcriptional pathway of adipogenesis and insulin sensitivity.
Mol. Cell
3:
151-158[CrossRef][Medline].
-deficient mice.
Proc. Natl. Acad. Sci.
94:
569-574This article has been cited by other articles:
![]() |
A. V. Das, J. James, S. Bhattacharya, A. N. Imbalzano, M. L. Antony, G. Hegde, X. Zhao, K. Mallya, F. Ahmad, E. Knudsen, et al. SWI/SNF Chromatin Remodeling ATPase Brm Regulates the Differentiation of Early Retinal Stem Cells/Progenitors by Influencing Brn3b Expression and Notch Signaling J. Biol. Chem., November 30, 2007; 282(48): 35187 - 35201. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhang, H. Fang, J. Zhou, and B. P. Herring A Novel Role of Brg1 in the Regulation of SRF/MRTFA-dependent Smooth Muscle-specific Gene Expression J. Biol. Chem., August 31, 2007; 282(35): 25708 - 25716. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sato, K. Miyake, H. Kaneoka, and S. Iijima Sumoylation of CCAAT/Enhancer-binding Protein {alpha} and Its Functional Roles in Hepatocyte Differentiation J. Biol. Chem., August 4, 2006; 281(31): 21629 - 21639. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. L. de la Serna, Y. Ohkawa, C. Higashi, C. Dutta, J. Osias, N. Kommajosyula, T. Tachibana, and A. N. Imbalzano The Microphthalmia-associated Transcription Factor Requires SWI/SNF Enzymes to Activate Melanocyte-specific Genes J. Biol. Chem., July 21, 2006; 281(29): 20233 - 20241. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-L. Wang, X. Shi, E. Salisbury, Y. Sun, J. H. Albrecht, R. G. Smith, and N. A. Timchenko Cyclin D3 Maintains Growth-Inhibitory Activity of C/EBP{alpha} by Stabilizing C/EBP{alpha}-cdk2 and C/EBP{alpha}-Brm Complexes. Mol. Cell. Biol., April 1, 2006; 26(7): 2570 - 2582. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Porse, T. A. Pedersen, M. S. Hasemann, M. B. Schuster, P. Kirstetter, T. Luedde, I. Damgaard, E. Kurz, C. K. Schjerling, and C. Nerlov The Proline-Histidine-Rich CDK2/CDK4 Interaction Region of C/EBP{alpha} Is Dispensable for C/EBP{alpha}-Mediated Growth Regulation In Vivo Mol. Cell. Biol., February 1, 2006; 26(3): 1028 - 1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Inayoshi, K. Miyake, Y. Machida, H. Kaneoka, M. Terajima, T. Dohda, M. Takahashi, and S. Iijima Mammalian Chromatin Remodeling Complex SWI/SNF Is Essential for Enhanced Expression of the Albumin Gene during Liver Development J. Biochem., February 1, 2006; 139(2): 177 - 188. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Mo, E. Kowenz-Leutz, Y. Laumonnier, H. Xu, and A. Leutz Histone H3 tail positioning and acetylation by the c-Myb but not the v-Myb DNA-binding SANT domain Genes & Dev., October 15, 2005; 19(20): 2447 - 2457. [Abstract] [Full Text] [PDF] |
||||